P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML.
Saved in:
| Title: | P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML. |
|---|---|
| Authors: | Dickinson, M., Herbert, K., Sardjono, C., Le, T., Link, E., Zannino, D., Ruell, S., Seymour, J.F., Kenealy, M., Prince, H.M. |
| Source: | Leukemia Research. May2013 Supplement, Vol. 37, pS147-S147. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01452126 |
|---|---|
| DOI: | 10.1016/S0145-2126(13)70323-0 |
